250 related articles for article (PubMed ID: 17073688)
1. IgE, allergic diseases, and omalizumab.
DuBuske LM
Curr Pharm Des; 2006; 12(30):3929-44. PubMed ID: 17073688
[TBL] [Abstract][Full Text] [Related]
2. Spotlight on omalizumab in allergic asthma.
Bang LM; Plosker GL
BioDrugs; 2004; 18(6):415-8. PubMed ID: 15571425
[TBL] [Abstract][Full Text] [Related]
3. A recombinant humanized anti-IgE monoclonal antibody (omalizumab) in the therapy of moderate-to-severe allergic asthma.
D'Amato G; Piccolo A; Salzillo A; Noschese P; D'Amato M; Liccardi G
Recent Pat Inflamm Allergy Drug Discov; 2007 Nov; 1(3):225-31. PubMed ID: 19075985
[TBL] [Abstract][Full Text] [Related]
4. Omalizumab: a review of its use in the management of allergic asthma.
Bang LM; Plosker GL
Treat Respir Med; 2004; 3(3):183-99. PubMed ID: 15219177
[TBL] [Abstract][Full Text] [Related]
5. Omalizumab: anti-IgE monoclonal antibody E25, E25, humanised anti-IgE MAb, IGE 025, monoclonal antibody E25, Olizumab, Xolair, rhuMAb-E25.
BioDrugs; 2002; 16(5):380-6. PubMed ID: 12408744
[TBL] [Abstract][Full Text] [Related]
6. Treatment of childhood asthma with anti-immunoglobulin E antibody (omalizumab).
Milgrom H; Berger W; Nayak A; Gupta N; Pollard S; McAlary M; Taylor AF; Rohane P
Pediatrics; 2001 Aug; 108(2):E36. PubMed ID: 11483846
[TBL] [Abstract][Full Text] [Related]
7. Anti-IgE monoclonal antibody (omalizumab) in the treatment of atopic asthma and allergic respiratory diseases.
D'Amato G; Liccardi G; Noschese P; Salzillo A; D'Amato M; Cazzola M
Curr Drug Targets Inflamm Allergy; 2004 Sep; 3(3):227-9. PubMed ID: 15379589
[TBL] [Abstract][Full Text] [Related]
8. Safety and tolerability of omalizumab (Xolair), a recombinant humanized monoclonal anti-IgE antibody.
Deniz YM; Gupta N
Clin Rev Allergy Immunol; 2005 Aug; 29(1):31-48. PubMed ID: 16222082
[TBL] [Abstract][Full Text] [Related]
9. Omalizumab: a recombinant humanized anti-IgE antibody for allergic asthma.
Ruffin CG; Busch BE
Am J Health Syst Pharm; 2004 Jul; 61(14):1449-59. PubMed ID: 15332692
[TBL] [Abstract][Full Text] [Related]
10. Anti-IgE antibodies for the treatment of asthma.
Buhl R
Curr Opin Pulm Med; 2005 Jan; 11(1):27-34. PubMed ID: 15591885
[TBL] [Abstract][Full Text] [Related]
11. What is new in antiimmunoglobulin E asthma therapy.
Berger WE
Allergy Asthma Proc; 2005; 26(6):428-34. PubMed ID: 16541964
[TBL] [Abstract][Full Text] [Related]
12. Anti-IgE monoclonal antibody: a new approach to the treatment of allergic respiratory diseases.
D'Amato G; Oldani V; Donner CF
Monaldi Arch Chest Dis; 2003; 59(1):25-9. PubMed ID: 14533279
[TBL] [Abstract][Full Text] [Related]
13. Omalizumab in asthma: approval and postapproval experience.
Chiang DT; Clark J; Casale TB
Clin Rev Allergy Immunol; 2005 Aug; 29(1):3-16. PubMed ID: 16222080
[TBL] [Abstract][Full Text] [Related]
14. Anti-immunoglobulin E treatment with omalizumab in allergic diseases: an update on anti-inflammatory activity and clinical efficacy.
Holgate ST; Djukanović R; Casale T; Bousquet J
Clin Exp Allergy; 2005 Apr; 35(4):408-16. PubMed ID: 15836747
[TBL] [Abstract][Full Text] [Related]
15. Omalizumab: an update on efficacy and safety in moderate-to-severe allergic asthma.
Chipps BE; Figliomeni M; Spector S
Allergy Asthma Proc; 2012; 33(5):377-85. PubMed ID: 23026179
[TBL] [Abstract][Full Text] [Related]
16. Omalizumab, a novel anti-IgE therapy in allergic disorders.
Babu KS; Arshad SH; Holgate ST
Expert Opin Biol Ther; 2001 Nov; 1(6):1049-58. PubMed ID: 11728235
[TBL] [Abstract][Full Text] [Related]
17. Omalizumab: a monoclonal anti-IgE antibody.
Belliveau PP
MedGenMed; 2005 Jan; 7(1):27. PubMed ID: 16369332
[TBL] [Abstract][Full Text] [Related]
18. Treating Moderate-to-Severe Allergic Asthma with a Recombinant Humanized Anti-IgE Monoclonal Antibody (Omalizumab).
D'Amato G; Bucchioni E; Oldani V; Canonica W
Treat Respir Med; 2006; 5(6):393-8. PubMed ID: 17154668
[TBL] [Abstract][Full Text] [Related]
19. Omalizumab for the treatment of exacerbations in children with inadequately controlled allergic (IgE-mediated) asthma.
Lanier B; Bridges T; Kulus M; Taylor AF; Berhane I; Vidaurre CF
J Allergy Clin Immunol; 2009 Dec; 124(6):1210-6. PubMed ID: 19910033
[TBL] [Abstract][Full Text] [Related]
20. [Anti-IgE therapy in persistent allergic asthma].
Skiepko R; Zietkowski Z; Tomasiak-Łozowska MM; Bodzenta-Łukaszyk A
Przegl Lek; 2009; 66(3):141-4. PubMed ID: 19689039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
